TCA
AMN icon

Transcend Capital Advisors’s AMN Healthcare AMN Stock Holding History

Transcend Capital Advisors’s Portfolio AMN Stock Details AMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-5,887
Closed -$488K – 487
2023
Q1 		$488K Sell
5,887
-8
-0.1% -$753 0.05% 294
2022
Q4 		$606K Buy
5,895
+8
+0.1% +$921 0.07% 261
2022
Q3 		$624K Hold
5,887
– – 0.07% 252
2022
Q2 		$646K Hold
5,887
– – 0.07% 259
2022
Q1 		$614K Buy
5,887
+92
+2% +$9.55K 0.05% 287
2021
Q4 		$709K Hold
5,795
– – 0.06% 255
2021
Q3 		$562K Buy
+5,795
New +$614K 0.05% 280

Other funds holding AMN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Transcend Capital Advisors's AMN Position: Q2 2023 in Review

Transcend Capital Advisors sold out of AMN Healthcare (AMN) in Q2 2023, closing a stake of 5,887 shares — an estimated $488K sold.

Transcend Capital Advisors first reported a position in AMN in Q3 2021 and held it in 7 quarters. The position peaked at $709K in Q4 2021. 425 funds tracked by Wall St. Rank hold AMN as of Q2 2023.

  • Transcend Capital Advisors reported no remaining AMN Healthcare position as of Q2 2023 after selling out during the quarter.
  • Transcend Capital Advisors sold 5,887 AMN Healthcare shares in Q2 2023, an estimated $488K.
  • Transcend Capital Advisors first reported a position in AMN Healthcare in Q3 2021 and held it in 7 quarters.
  • Transcend Capital Advisors's AMN Healthcare position peaked at $709K in Q4 2021.
  • 425 funds tracked by Wall St. Rank held AMN Healthcare as of Q2 2023.

Based on Transcend Capital Advisors's 13F filing for Q2 2023, filed 13 Jul 2023.